市場調査レポート

商品コード

1563387

医薬品スクリーニングの市場規模、シェア、成長分析、製品・サービス別、サンプルタイプ別、薬物タイプ別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Drug Screening Market Size, Share, Growth Analysis, By Product & Service, By Sample Type, By Drug Type, By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年09月26日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 778,146円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 910,284円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,042,422円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
目次

概要

サンプル依頼リストに入れる

医薬品スクリーニングの世界市場規模は、2022年に89億米ドルと評価され、2023年の103億7,000万米ドルから2031年には351億8,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは16.5%で成長する見通しです。

世界の医薬品スクリーニング市場は、ヘルスケア分野で急速に拡大しており、個人の薬物やその代謝物の検出に焦点を当てています。この市場は、職場、病院、スポーツ組織、法執行機関など、さまざまな環境において不可欠であり、違法物質の使用者や処方薬の誤用者の特定に役立っています。医薬品スクリーニング市場の成長を後押ししている要因はいくつかあります。主な要因は、薬物乱用や薬物中毒の蔓延が拡大していることで、効果的なスクリーニング技術に対する需要が高まっています。世界中の政府や組織が薬物乱用の社会的・経済的影響を認識するようになり、薬物検査を義務付ける規制と政策が厳しくなっています。さらに、職場の安全性が重視されるようになり、多くの企業が従業員の生産性を高め、労働災害を減らし、法的リスクを抑えるために薬物フリー政策を導入しています。また、医薬品スクリーニング技術の進歩や、さまざまな分野で信頼性の高い検査方法が求められていることも、市場の拡大を後押ししています。医薬品スクリーニングの重要性は、これらの要因や進化する規制によって高まり続けているため、継続的な技術革新が市場の将来を形成しながら、今後数年間でさらに成長すると予想されます。

市場概要
医薬品スクリーニングサービス
- ラボ試験サービス
- オンサイトテストサービス
医薬品スクリーニング製品
- 分析機器
- タイプ別
- アルコール検知器
- 燃料電池アルコール検知器
- 半導体アルコール検知器
- その他のアルコール検知器
- 免疫測定分析装置
- クロマトグラフィー機器
- モダリティ別
- ハンドヘルド医薬品スクリーニング製品
- ベンチトップ医薬品スクリーニング製品
- 迅速検査装置
- 尿検査装置
- 薬物検査カップ
- ディップカード
- 薬物検査カセット
- 口腔液検査装置
- 消耗品
- アッセイキット
- サンプル収集装置
- キャリブレーターとコントロール
- その他の消耗品

医薬品スクリーニング市場：サンプルタイプ別

市場概要
尿サンプル
呼気サンプル
口腔液サンプル
毛髪サンプル
その他のサンプル

医薬品スクリーニング市場：薬物タイプ別

市場概要
大麻
アルコール
コカイン
オピオイド
アンフェタミンとメタンフェタミン
その他の薬物

医薬品スクリーニング市場：エンドユーザー別

市場概要
薬物検査研究所
ワークプレイス
刑事司法制度と法執行機関
病院
薬物治療センター
個人ユーザー
疼痛管理センター
学校と大学
その他のエンドユーザー

医薬品スクリーニング市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Quest Diagnostics（US）
Abbott（US）
OraSure Technologies Inc.（US）
Alfa Scientific Designs Inc.（US）
Thermo Fisher Scientific Inc.（US）
Dragerwerk AG & Co. KGaA（Germany）
Lifeloc Technologies, Inc.（US）
MPD Inc.（US）
Omega Laboratories, Inc.（US）
Premier Biotech, Inc.（US）
Psychemedics Corporation（US）
F. Hoffmann-La Roche Ltd.（Switzerland）
Shimadzu Corporation（Japan）
Siemens Healthineers AG（Germany）
American Bio Medica Corporation（US）
ACM Global Laboratories（US）
CareHealth America Corp.（US）
Clinical Reference Laboratory, Inc.（US）
Intoximeters（US）
Sciteck, Inc.（US）
AccuSourceHR, Inc.（US）
Cordant Health Solutions（US）
Intoxalock（US）
Millennium Health（US）
AdvaCare Pharma（US）

Product Code: SQMIG35D2198

Global Drug Screening Market size was valued at USD 8.9 billion in 2022 and is poised to grow from USD 10.37 billion in 2023 to USD 35.18 billion by 2031, growing at a CAGR of 16.5% during the forecast period (2024-2031).

The global drug screening market is expanding rapidly within the healthcare sector, focusing on detecting drugs or their metabolites in individuals. This market is essential across multiple environments, including workplaces, hospitals, sports organizations, and law enforcement agencies, where it helps identify those using illegal substances or misusing prescription drugs. Several factors are fueling the growth of the drug screening market. A major driver is the increasing prevalence of drug abuse and addiction, which has heightened the demand for effective screening techniques. Governments and organizations worldwide are becoming more aware of the social and economic impacts of drug abuse, leading to stricter regulations and policies that mandate drug testing. Additionally, there is a growing emphasis on workplace safety, with many companies implementing drug-free policies to enhance employee productivity, reduce workplace accidents, and limit legal risks. The market's expansion is also supported by advancements in drug screening technology and the need for reliable testing methods in various sectors. As the importance of drug screening continues to rise, driven by these factors and evolving regulations, the market is expected to grow further in the coming years, with ongoing innovations shaping its future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Screening market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Screening Market Segmental Analysis

Global Drug Screening Market is segmented by Product & Service, Sample Type, application, end user and region. Based on Product & Service, the market is segmented into Drug Screening Services, and Drug Screening Products. Based on Sample Type, the market is segmented into Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, and Other Samples. Based on Drug Type, the market is segmented into Cannabis, Alcohol, Cocaine, Opioids, Amphetamine and Methamphetamine, and Other Drugs. Based on end user, the market is segmented into Drug Testing Laboratories, Workplaces, Criminal Justice Systems and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Drug Screening Market

The growing use of drug screening products and services on the road is expected to drive the overall expansion of the market, particularly as the prevalence of illicit drug use increases. Additionally, rising drug use among teenagers is likely to further boost market growth. The ease of implementing drug screening and its effectiveness in workplace testing are also contributing factors to this market expansion. However, the increase in government spending to combat drug trafficking may moderate the market's growth. Despite this, the market is anticipated to benefit from the rising incidence of traffic accidents related to drugged driving and prescription medication abuse, which will further accelerate its growth in the future.

Restraints in the Global Drug Screening Market

In certain environments, particularly workplaces, drug testing is perceived as an invasion of employee privacy, which is likely to hinder market growth. These privacy concerns may lead to resistance and slow the expansion of the drug screening market. Additionally, the industry faces potential challenges from regional restrictions on drug use and issues with the accuracy of breathalyzers. These factors could further impact the growth and adoption of drug screening solutions in various settings.

Market Trends of the Global Drug Screening Market

The global drug screening market is evolving with several prominent trends shaping its development. One major trend is the increasing adoption of advanced technologies, such as liquid chromatography-mass spectrometry (LC-MS) and immunoassays. These innovations are improving the sensitivity and accuracy of drug testing methods, enhancing the overall effectiveness of screening procedures. Another notable trend is the rising emphasis on oral fluid drug testing. Saliva-based tests offer a non-invasive and convenient alternative to traditional urine and blood tests. Although they have a shorter detection window, oral fluid tests provide real-time detection of drug use, making them particularly useful for post-accident and roadside testing. The market is also seeing growth in rapid on-site testing, expanded drug panels, and the integration of artificial intelligence (AI) and machine learning (ML). These advancements are aimed at increasing the accuracy, convenience, and efficiency of drug screening processes.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Drug Screening Market by Product & Service

Market Overview
Drug Screening Services
- Laboratory Testing Services
- On-site Testing Services
Drug Screening Products
- Analytical Instruments
- By Type
- Breathalyzers
- Fuel-cell Breathalyzers
- Semiconductor Breathalyzers
- Other Breathalyzers
- Immunoassay analyzers
- Chromatography instruments
- By Modality
- Hand-held drug screening products
- Benchtop drug screening products
- Rapid Testing Devices
- Urine testing devices
- Drug testing cups
- Dip cards
- Drug testing cassettes
- Oral fluid testing devices
- Consumables
- Assay kits
- Sample collection devices
- Calibrators and controls
- Other consumables

Drug Screening Market by Sample Type

Market Overview
Urine Samples
Breath Samples
Oral Fluid Samples
Hair Samples
Other Samples

Drug Screening Market by Drug Type

Market Overview
Cannabis
Alcohol
Cocaine
Opioids
Amphetamine And Methamphetamine
Other Drugs

Drug Screening Market by End User

Market Overview
Drug Testing Laboratories
Workplaces
Criminal Justice Systems and Law Enforcement Agencies
Hospitals
Drug Treatment Centers
Individual Users
Pain Management Centers
Schools And Colleges
Other End Users

Drug Screening Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Quest Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OraSure Technologies Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alfa Scientific Designs Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dragerwerk AG & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lifeloc Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MPD Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omega Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Premier Biotech, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Psychemedics Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
American Bio Medica Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACM Global Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CareHealth America Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clinical Reference Laboratory, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intoximeters (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sciteck, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AccuSourceHR, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cordant Health Solutions (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intoxalock (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Millennium Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AdvaCare Pharma (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments